Susan Rotzinger

Susan Rotzinger

UNVERIFIED PROFILE

Are you Susan Rotzinger?   Register this Author

Register author
Susan Rotzinger

Susan Rotzinger

Publications by authors named "Susan Rotzinger"

Are you Susan Rotzinger?   Register this Author

33Publications

830Reads

39Profile Views

White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study.

Biol Psychiatry Cogn Neurosci Neuroimaging 2019 10 12;4(10):913-924. Epub 2019 Jun 12.

Department of Psychology, Neuroscience & Behavior, McMaster University, Hamilton, Ontario, Canada; Imaging Research Center, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpsc.2019.05.016DOI Listing
October 2019

The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

J Psychiatry Neurosci 2019 07;44(4):223-236

From the Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alta., Canada (MacQueen, Hassel, Addington, Sharma); the Rotman Research Institute, Baycrest, and Department of Medical Biophysics, University of Toronto, Toronto, Ont., Canada (Arnott, Zamyadi, Strother); the Department of Psychology, Queen’s University, Kingston, Ont., Canada (Bowie, Harkness, Milev); the Department of Radiology, University of Calgary, Calgary, Alta., Canada (Bray, Lebel); the Alberta Children’s Hospital Research Institute, Calgary, Alta., Canada (Bray, Lebel); the Child and Adolescent Imaging Research (CAIR) Program, Calgary, Alta., Canada (Bray, Lebel); the Department of Psychology, Neuroscience and Behaviour, McMaster University, and St. Joseph’s Healthcare Hamilton, Hamilton, Ont., Canada (Hall); the Krembil Research Institute and Centre for Mental Health, University Health Network, Toronto, Ont., Canada (Downar); the Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ont., Canada (Downar); the Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ont., Canada (Downar, Müller, Rizvi, Rotzinger, Kennedy); the Department of Psychiatry, Krembil Research Centre, University Health Network, University of Toronto, Toronto, Ont., Canada (Foster, Rotzinger, Kennedy); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, and St. Joseph’s Healthcare Hamilton, Hamilton, Ont., Canada (Foster, Frey); the Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, Toronto, Ont., Canada (Goldstein); the Departments of Psychiatry and Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Ont., Canada (Goldstein); the Department of Computer Science, University of Alberta, Edmonton, Alta., Canada (Harris); the University of British Columbia and Vancouver Coastal Health Authority, Vancouver, B.C., Canada (Lam, Vila-Rodriguez); the Department of Psychiatry, Queen’s University and Providence Care Hospital, Kingston, Ont., Canada (Milev, Soares); the Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ont., Canada (Müller); the Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA (Parikh); the Arthur Sommer Rotenberg Suicide and Depression Studies Program, Li Ka Shing Knowledge Institute and St. Michael’s Hospital, Toronto, Ont., Canada (Rizvi); the Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ont., Canada (Rizvi); the Department of Psychiatry, St. Michael’s Hospital, University of Toronto, Toronto, Ont., Canada (Rotzinger, Soares, Yu); McGill University, Montréal, Que., Canada (Turecki); the Douglas Mental Health University Institute, Frank B. Common, Montréal, Que., Canada (Turecki); and the Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ont., Canada (Kennedy).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/jpn.180036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606427PMC
July 2019

Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.

Int J Neuropsychopharmacol 2017 08;20(8):619-623

McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University, Verdun, Quebec, Canada (Drs Fiori, Lopez, Richard-Devantoy, Berlim, Chachamovich, Jollant, and Turecki); Department of Psychiatry, University Health Network, University of Toronto, Toronto, Ontario, Canada (Drs Foster, Rotzinger, and Kennedy).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ijnp/pyx034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570004PMC
August 2017

Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder.

Pharmacogenomics 2015 Nov 10;16(17):1919-29. Epub 2015 Nov 10.

Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, 250 College Street, Toronto, ON M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.136DOI Listing
November 2015

Treatment-resistant depression in primary care across Canada.

Can J Psychiatry 2014 Jul;59(7):349-57

Psychiatrist, Department of Psychiatry, University Health Network, Toronto, Ontario; Professor, Department of Psychiatry, University of Toronto, Toronto, Ontario; Professor, Institute of Medical Sciences, University of Toronto, toronto, Ontario.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086317PMC
http://dx.doi.org/10.1177/070674371405900702DOI Listing
July 2014

Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization.

Br J Pharmacol 2011 Feb;162(3):574-83

Centre for the Neurobiology of Stress, Department of Psychology, University of Toronto Scarborough, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1476-5381.2010.01055.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041248PMC
February 2011

Behavioral effects of neuropeptides in rodent models of depression and anxiety.

Peptides 2010 Apr 21;31(4):736-56. Epub 2009 Dec 21.

Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.peptides.2009.12.015DOI Listing
April 2010

Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1).

Peptides 2007 Jul 22;28(7):1406-15. Epub 2007 Jun 22.

Department of Cell and Systems Biology, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.peptides.2007.05.014DOI Listing
July 2007

Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats.

Psychopharmacology (Berl) 2004 Dec 27;177(1-2):111-20. Epub 2004 May 27.

Department of Psychology, University of Toronto, Toronto, ON, Canada, M5S 3G3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-004-1912-9DOI Listing
December 2004

Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.

Brain Res 2004 Mar;1001(1-2):95-107

Department of Psychology, University of Toronto, Toronto, Ontario, Canada M5S 3G3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainres.2003.10.064DOI Listing
March 2004

Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

J Psychiatry Neurosci 2003 May;28(3):171-81

Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ont.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC161741PMC
May 2003

Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.

J Psychiatry Neurosci 2003 Mar;28(2):115-25

Department of Psychiatry, Walter Mackenzie Health Sciences Centre, University of Alberta, Edmonton, Alta.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC161732PMC
March 2003

Cholecystokinin modulation of mesolimbic dopamine function: regulation of motivated behaviour.

Pharmacol Toxicol 2002 Dec;91(6):404-13

Department of Psychology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0773.2002.910620.xDOI Listing
December 2002

Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes.

Eur Neuropsychopharmacol 2002 Apr;12(2):91-100

Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada T6G 2B7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0924-977x(02)00005-6DOI Listing
April 2002